Budesonide marketed by Salix Pharmaceuticals, Inc. under NDC Code 65649-651-03
NDC Code(s) : 65649-651-02, 65649-651-03
Packager : Salix Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Ucerisbudesonide AEROSOL, FOAM |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
NDC 65649-651-03
Rx only
UCERIS®
(budesonide) rectal foam
2mg/ actuation
For rectal administration only, as directed
by a physician. Shake well before using.
Each canister contains 14 metered doses.
Net weight 33.4 g per canister.
Salix
PHARMACEUTICALS
![Carton](/xml/230e4596-2a9b-4d55-b0a0-0cabbcff5289/image-01.jpg)
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.